Femoral vein stenting versus endovenectomy as adjuncts to iliofemoral venous stenting in extensive chronic iliofemoral venous obstruction

Phlebology. 2024 Jul;39(6):393-402. doi: 10.1177/02683555241236824. Epub 2024 Feb 27.

Abstract

Purpose: To compare femoral endovenectomy with the creation of an arteriovenous fistula (FE + AVF), versus iliofemoral endovenous stenting with the concurrent extended femoral vein (FV-S) stenting in patients with chronic iliofemoral venous obstruction (IFVO).

Materials and methods: In a randomized prospective single-center study, 48 received (FV-S), while the other 54 had (FE + AVF).

Results: There were no statistically significant differences in the primary outcomes between the two groups (FV-S) and (FE + AVF) (59% vs 56.8%, 75% vs 79.1%, respectively). At a median of 13 months after the treatment. However, the FV-S group's patients experienced fewer postoperative problems (p = .012), shorter procedures (p = .001), and shorter stays in the hospital (p = .025).

Conclusion: There is no difference between the efficacy and symptomatic resolution of the FV-S group and the FE + AVF group at the same time, FV-S has lower postoperative complications and a shorter procedure duration and hospital stay.

Keywords: Arteriovenous fistula; chronic iliofemoral venous obstruction; chronic venous insufficiency; endovenous venoplasty; extended femoral vein; femoral endovenectomy; femoral vein stent; iliac venous recanalization; post-thrombotic syndrome; venous hypertension.

Publication types

  • Randomized Controlled Trial
  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Chronic Disease
  • Endovascular Procedures / instrumentation
  • Female
  • Femoral Vein* / surgery
  • Humans
  • Iliac Vein* / surgery
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Prospective Studies
  • Stents*